Retrospective Study of the Impact of Drug Eluting Stents
NCT00487604 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 9800
Last updated 2007-08-02
Summary
The purpose of this study is to determine whether the use of drug eluting stents is associated with higher rates of death, myocardial infarction, and major bleeding. In addition, the overall economic costs of implanting drug eluting stents compared to bare metal stents will be assessed.
Conditions
Sponsors & Collaborators
-
Providence Health & Services
lead OTHER
Principal Investigators
-
Michael E. Ring, MD · Providence Health & Services
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-05-31
- Completion
- 2008-05-31
Countries
- United States
Study Locations
More Related Trials
-
Drug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk Angioplasty
NCT04885816 ·Status: TERMINATED ·Phase: NA
-
The COOPerative Establishment for Necessary Investigation in Clinical Outcome After Stenting
NCT01534221 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy Study Comparing 3 New Types of Coronary Stents
NCT01166685 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Coronary In-Stent Restenosis
NCT01735825 ·Status: COMPLETED ·Phase: NA
-
the Effect of Prolonged Inflation Time During Stents Deployment for ST-elevation Myocardial Infarction
NCT03199014 ·Status: UNKNOWN ·Phase: NA
-
Prospective Assessment of Efficacy and Safety of Drug Eluting Stents
NCT02313038 ·Status: COMPLETED
-
Efficacy Study of Rapamycin- vs. Zotarolimus-Eluting Stents to Reduce Coronary Restenosis
NCT00598533 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents
NCT01711931 ·Status: COMPLETED ·Phase: PHASE4
-
Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent
NCT00793221 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions
NCT00595647 ·Status: TERMINATED ·Phase: PHASE4
-
Bare -Metal Stents and Drug -Eluting Stents in the Treatment of Patients With Vertebral Artery Ostium Stenosis
NCT02197559 ·Status: COMPLETED
-
Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
NCT01186133 ·Status: RECRUITING
-
Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System
NCT01788150 ·Status: COMPLETED ·Phase: NA
-
Drug-eluting Stents to Treat Unprotected Coronary Left Main Disease
NCT00598637 ·Status: COMPLETED ·Phase: PHASE4
-
Drug-Coated Balloon Coronary Angioplasty Versus Stenting for Treatment of Disease Adjacent to a Chronic Total Occlusion.
NCT04881812 ·Status: UNKNOWN ·Phase: NA
-
Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis
NCT00369356 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Intra-stent Tissue Evaluation Within BMS and DES > 3 Years Since Implantation
NCT01835301 ·Status: UNKNOWN
-
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
NCT00638794 ·Status: COMPLETED
-
A Randomized Comparison of Long-Term Healing Between Biodegradable- Versus Durable-Polymer Everolimus Eluting Stents in STEMI
NCT03440801 ·Status: COMPLETED ·Phase: NA
-
Outcomes of Drug Coated Balloon Angioplasty, A UK Real Life Experience From 2009 to 2015
NCT03603210 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population
NCT01556126 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Everolimus-Eluting Versus Zotarolimus-Eluting Sten for Coronary Lesions in Acute Myocardial Infarction
NCT01347554 ·Status: COMPLETED ·Phase: PHASE4
-
Primary FIbrinolysis and Secondary STenting Versus immEdiate Stenting in ST-segment Elevation Myocardial Infarction
NCT04663932 ·Status: UNKNOWN ·Phase: NA
-
The 3D Stent Study
NCT06898021 ·Status: RECRUITING
-
Alpine vs. Xpedition: Evaluation of Stent Delivery System
NCT03451617 ·Status: UNKNOWN ·Phase: NA